Former Dept Chair at National Cancer Hospital Charged with Taking ¥1.7 Million Bribe from Supplier

The Metropolitan Police Department
17:20 JST, September 21, 2023
Yusuke Hashimoto, a former department chair at the National Cancer Center Hospital East, has been arrested on suspicion of taking a bribe in exchange for favoring a medical equipment supplier during his tenure. Hashimoto, 47, headed the Department of Hepatobiliary and Pancreatic Oncology at the hospital in Kashiwa, Chiba Prefecture.
The Tokyo Metropolitan Police made the arrest Thursday, and are actively investigating the matter on suspicion of collusion between Hashimoto and the supplier.
According to sources familiar with the case, Hashimoto is alleged to have taken a roughly ¥1.7 million bribe in May 2021 from medical equipment manufacturer Zeon Medical Inc., headquartered in Chiyoda Ward, Tokyo. The company manufactures and sells stents, and Hashimoto is thought to have pushed the use of these stents at the hospital in exchange for the bribe.
The former president of Zeon Medical, Noboru Yanagida, 67, has also been arrested on a bribery charge by the police.
"Society" POPULAR ARTICLE
-
M4.9 Earthquake Hits Tokyo, Neighboring Prefectures
-
M7.5 Earthquake Hits Northern Japan; Tsunami Waves Observed in Hokkaido, Aomori and Iwate Prefectures
-
Tsukiji Market Urges Tourists to Avoid Visiting in Year-End
-
Israeli Tourists Refused Accommodation at Hotel in Japan’s Nagano Pref., Prompting Protest by Israeli Embassy and Probe by Prefecture
-
M5.7 Earthquake Hits Japan’s Kumamoto Pref., Measuring Upper 5 Intensity, No Tsunami Expected
JN ACCESS RANKING
-
Keidanren Chairman Yoshinobu Tsutsui Visits Kashiwazaki-Kariwa Nuclear Power Plant; Inspects New Emergency Safety System
-
Imports of Rare Earths from China Facing Delays, May Be Caused by Deterioration of Japan-China Relations
-
University of Tokyo Professor Discusses Japanese Economic Security in Interview Ahead of Forum
-
Japan Pulls out of Vietnam Nuclear Project, Complicating Hanoi’s Power Plans
-
Govt Aims to Expand NISA Program Lineup, Abolish Age Restriction

